MD1977G2 - Metodă de pronosticare a evoluţiei sindromului de insuficienţă cardiacă - Google Patents
Metodă de pronosticare a evoluţiei sindromului de insuficienţă cardiacă Download PDFInfo
- Publication number
- MD1977G2 MD1977G2 MDA20000092A MD20000092A MD1977G2 MD 1977 G2 MD1977 G2 MD 1977G2 MD A20000092 A MDA20000092 A MD A20000092A MD 20000092 A MD20000092 A MD 20000092A MD 1977 G2 MD1977 G2 MD 1977G2
- Authority
- MD
- Moldova
- Prior art keywords
- effort
- course
- athenolol
- tasm
- ict
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000004873 systolic arterial blood pressure Effects 0.000 abstract 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 abstract 1
- 208000000059 Dyspnea Diseases 0.000 abstract 1
- 206010013975 Dyspnoeas Diseases 0.000 abstract 1
- 230000001919 adrenal effect Effects 0.000 abstract 1
- 229940097217 cardiac glycoside Drugs 0.000 abstract 1
- 239000002368 cardiac glycoside Substances 0.000 abstract 1
- 229960005156 digoxin Drugs 0.000 abstract 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 abstract 1
- 229960003401 ramipril Drugs 0.000 abstract 1
- 229930002534 steroid glycoside Natural products 0.000 abstract 1
- 150000008143 steroidal glycosides Chemical class 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Invenţia se referă la medicină, în special la cardiologie.Esenţa invenţiei constă în aceea că se efectuează examenul clinic, paraclinic, în cadrul căruia se efectuează cicloergometria, după care se determină criteriul de întrerupere a efortului, tratamentul aplicat, în afară de adrenoblocante, include suplimentar administrarea preparatelor vasodilatatoare periferice şi a glicozidelor cardiace, iar funcţia discriminantă (F) se calculează conform formulei:F = 2,241-1,145·TA-10,937· ICT + 0,040· TAS- 0,002· DP+ 0,005·TASM + 0,695· CÎE,în careTA - indicele ce caracterizează tratamentul aplicat şi, în funcţie de preparatele utilizate, primeşte valorile: 1 (Atenolol), 2 (Atenolol+ Ramipril), 3 (Isorbinitrat+ Digogsină);ICT - indicele cardiotoracal;TAS - tensiunea arterială sistolică (fără efort);DP - dublu produs (unităţi);TASM - tensiunea arterială sistolică la efort maxim;CÎE - criteriul de întrerupere a efortului, care ia valorile: 1 pentru dispnee, 2 pentru FCC submaximală, pe baza cărora se apreciază variantele de evoluţie a sindromului de insuficienţă cardiacă. În cazul în care F > 0 se face pronosticul unui efect de ameliorare, iar când F < 0 - a unui efect de agravare.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000092A MD1977G2 (ro) | 2000-05-26 | 2000-05-26 | Metodă de pronosticare a evoluţiei sindromului de insuficienţă cardiacă |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000092A MD1977G2 (ro) | 2000-05-26 | 2000-05-26 | Metodă de pronosticare a evoluţiei sindromului de insuficienţă cardiacă |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MD20000092A MD20000092A (ro) | 2001-12-31 |
| MD1977F2 MD1977F2 (ro) | 2002-08-31 |
| MD1977G2 true MD1977G2 (ro) | 2003-02-28 |
Family
ID=19739600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20000092A MD1977G2 (ro) | 2000-05-26 | 2000-05-26 | Metodă de pronosticare a evoluţiei sindromului de insuficienţă cardiacă |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1977G2 (ro) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3181G2 (ro) * | 2005-10-24 | 2007-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Metodă de pronosticare a riscului apariţiei infecţiilor septico-purulente nozocomiale |
| MD301Z (ro) * | 2010-06-02 | 2011-07-31 | Николай АРМЕНЧА | Metodă de apreciere a stării funcţionale a sistemului cardiovascular uman |
-
2000
- 2000-05-26 MD MDA20000092A patent/MD1977G2/ro unknown
Non-Patent Citations (1)
| Title |
|---|
| Лопатин М. Потенциальные возможности применения бета- адреноблокаторов при сердечной недостаточности. Кардиология, 1992, Том 32, с. 79-82 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3181G2 (ro) * | 2005-10-24 | 2007-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Metodă de pronosticare a riscului apariţiei infecţiilor septico-purulente nozocomiale |
| MD301Z (ro) * | 2010-06-02 | 2011-07-31 | Николай АРМЕНЧА | Metodă de apreciere a stării funcţionale a sistemului cardiovascular uman |
Also Published As
| Publication number | Publication date |
|---|---|
| MD20000092A (ro) | 2001-12-31 |
| MD1977F2 (ro) | 2002-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Regnier et al. | Haemodynamic effects of dopamine in septic shock | |
| CA2220505A1 (en) | N,o-carboxymethylchitosan for prevention of surgical adhesions | |
| NO981781L (no) | Ekstrakter av haibrusk | |
| AU4319493A (en) | Indolocarbazole imides and their use | |
| AU4553700A (en) | Substitution infusion fluid and citrate anticoagulation | |
| CA2244454A1 (en) | Use of nitric monoxide for preparing medication for intravascular administration | |
| MD1977G2 (ro) | Metodă de pronosticare a evoluţiei sindromului de insuficienţă cardiacă | |
| Yaacobi et al. | Reactive oxygen species in the process of labor | |
| HUP9801593A2 (hu) | Benazeprilt vagy benazeprilátot és valzartánt tartalmazó kombinált gyógyszerkészítmények és azok alkalmazása | |
| Bussmann et al. | Nitroglycerin in acute myocardial infarction X. Effect of small and large doses of nitroglycerin on sigma ST segment deviation—Experimental and clinical results | |
| AU4674496A (en) | Novel iron chelator and inhibitor of iron-mediated oxidation | |
| DE60013823D1 (de) | Teilbare hüllenanordnung mit okklusionsballon | |
| GR3020419T3 (en) | 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them | |
| AU2002249692A1 (en) | Method for reducing cellular damage resulting from hypoxia/ischaemia-related inflammation | |
| DK0451760T3 (da) | Nitratoalkancarboxylsyrederivater og fremgangsmåde til deres fremstilling | |
| Gorback et al. | The accuracy of rapid oscillometric blood pressure determination | |
| DE69913716T2 (de) | Hemmung der sichelbildung von erythrozyten mittels n-l-alpha-aspartyl-l-phenylalanine 1-methylester | |
| CN114316081A (zh) | 一种具有抑制SARS-CoV-2活性的长茎葡萄蕨藻硫酸化多糖及其制备方法和应用 | |
| RU2007119C1 (ru) | Способ получения крови у доноров | |
| Wada et al. | Calcification in culprit lesions of coronary artery disease | |
| GR3027725T3 (en) | Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions | |
| RU2258513C2 (ru) | Способ защиты головного мозга и шейно-верхнегрудного отдела спинного мозга от ишемии при реконструктивных операциях на грудной аорте | |
| JPS55143912A (en) | Useful preparation comprising bencyclane fumarate | |
| Antia | Laparoscopic cholecystectomy. | |
| FUJISAWA et al. | A case of a ruptured internal carotid artery after radical neck dissection that was treated by embolization |